291 General discussion 9 36. van Limburg M, van Gemert-Pijnen Je Fau - Nijland N, Nijland N Fau - Ossebaard HC, Ossebaard Hc Fau - Hendrix RMG, Hendrix Rm Fau - Seydel ER, Seydel ER. Why business modeling is crucial in the development of eHealth technologies. (1438-8871 (Electronic)). 37. Prahalad CK, Ramaswamy V. Co-creation experiences: The next practice in value creation. Journal of Interactive Marketing. 2004;18(3):5-14. 38. Lluch M. Incentives for telehealthcare deployment that support integrated care: a comparative analysis across eight European countries. (1568-4156 (Print)). 39. Nutbeam D. Evaluation in a nutshell : a practical guide to the evaluation of health promotion programs / Don Nutbeam, Adrian Bauman. Bauman AE, editor. North Ryde, N.S.W: McGraw-Hill; 2006. 40. Greenhalgh T, Wherton J, Papoutsi C, Lynch J, Hughes G, A’Court C, et al. Beyond Adoption: A New Framework for Theorizing and Evaluating Nonadoption, Abandonment, and Challenges to the Scale-Up, Spread, and Sustainability of Health and Care Technologies. Journal of medical Internet research. 2017;19(11):e367. 41. Guyatt GH, Haynes RB, Jaeschke RZ, Cook DJ, Green L, Naylor CD, et al. Users’ Guides to the Medical LiteratureXXV. Evidence-Based Medicine: Principles for Applying the Users’ Guides to Patient Care. JAMA. 2000;284(10):1290-6. 42. Handbook of Research Synthesis and Meta-Analysis, The. Cooper H, Hedges LV, Valentine JC, editors: Russell Sage Foundation; 2009. 43. Zuidgeest MGP, Goetz I, Groenwold RHH, Irving E, van Thiel GJMW, Grobbee DE. Series: Pragmatic trials and real world evidence: Paper 1. Introduction. Journal of Clinical Epidemiology. 2017;88:7-13. 44. Sedgwick P. Explanatory trials versus pragmatic trials. BMJ : British Medical Journal. 2014;349:g6694. 45. Bonten TA-O, Rauwerdink AA-O, Wyatt JA-O, Kasteleyn MA-O, Witkamp LA-O, Riper HAO, et al. Online Guide for Electronic Health Evaluation Approaches: Systematic Scoping Review and Concept Mapping Study. (1438-8871 (Electronic)). 46. Pawson R, Greenhalgh T, Harvey G, Walshe K. Realist review--a new method of systematic review designed for complex policy interventions. J Health Serv Res Policy. 2005;10 Suppl 1:21-34. 47. Petropoulou M, Efthimiou O, Rücker G, Schwarzer G, Furukawa TA, Pompoli A, et al. A review of methods for addressing components of interventions in meta-analysis. PLOS ONE. 2021;16(2):e0246631. 48. Tanner-Smith EE, Grant S. Meta-Analysis of Complex Interventions. (1545-2093 (Electronic)). 49. Sedgwick P. Randomised controlled trials: internal versus external validity. BMJ : British Medical Journal. 2014;348:g1742. 50. Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. (1756-1833 (Electronic)). 51. Abbott JH. The Distinction Between Randomized Clinical Trials (RCTs) and Preliminary Feasibility and Pilot Studies: What They Are and Are Not. Journal of Orthopaedic & Sports Physical Therapy. 2014;44(8):555-8. 52. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321(7262):694.
RkJQdWJsaXNoZXIy MTk4NDMw